🔗 Share this article

Acclaimed R&B singer D’Angelo died on the fourteenth of October at 51 years old after a personal fight with pancreatic malignancy.

“The shining star of our household has dimmed his light for us in this life,” his family stated. “After a prolonged and courageous struggle with cancer, we are deeply saddened to announce that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album achieved the fourth spot on the R&B charts, went platinum soon after, and earned several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his music career into the stratosphere. The album premiered at the top spot on both the R&B charts and the main album chart. He received two Grammys: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal showed the artist, notably bare to his waist, performing directly into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious vehicle accident that left him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the R&B chart and a award for Best R&B Album.

Once more, in his own enigmatic fashion, D’Angelo had limited public appearances in the subsequent period.

The musician was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months leading up to his passing, he had apparently been in the hospital for an extended period and in palliative care for two weeks.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic cancer, one of the deadliest and least preventable types of the disease, on a gifted artist whose existence was cut short.

“We are saddened that he can only provide dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic cancer affects the digestive organ, a tiny gland that generates insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the human system make it more difficult to detect malignancy.

Even though this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is causes 7% of malignancy fatalities.

Nearly seventy thousand individuals will be found to have pancreatic cancer and roughly fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor therapies, and a narrow opportunity to make a significant difference on the lives of people,” noted a medical oncologist.

Because pancreatic cancer seldom produces early symptoms, it’s frequently identified only after the disease is advanced. Although a patient has indicators they are often vague and may be mistaken for a number of everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and consulting your doctor if there are unfamiliar signs,” said a health expert.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is typically found in individuals in the 65 to 75 age bracket. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“Pancreatic cancer identified before the age of 50 is deemed rare, yet alarmingly, doctors are noticing a growing number of younger patients affected by this condition,” commented a specialist.

Genetic Background Affects Cancer Risk

Without reliable detection methods for pancreatic cancer, experts emphasized the significance of understanding your relatives’ cancer history. Certain contributing elements, such as smoking and obesity also play a role in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The initial action toward lowering one’s chance of this condition is assessing personal risk factors. Individuals should review their family history, genetic background, and health issues, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a medical professional.

Inherited genetic risk factors are associated with as much as ten percent of all this malignancy instances. If a relative in your household has had this disease, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those having elevated risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he explained.

For those wishing to lower their chance, lifestyle changes may have an effect. The best action you can take to lower your risk of this disease is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Excessive drinking is associated with pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding drinks may help lower your chance.

Managing your weight or shedding pounds may also aid reduce your risk. Individuals with excess weight are 20% more likely to develop this disease. Pancreatic cancer also is more frequent in those with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.

Despite this disease’s grim outlook, there is reason for optimism.

“We are making progress with therapies and newer combination chemotherapy. There are developing precision medicines that already are making an impact,” remarked a specialist.

For numerous people, however, awareness about this uncommon but {dev